Kestra Medical Technologies Announces Inclusion in the Russell 2000® and Russell 3000® Indexes

Rhea-AI Summary

Kestra Medical Technologies (NASDAQ: KMTS), a wearable medical device and digital healthcare company, has announced its inclusion in the Russell 3000® Index and Russell 2000® Index, effective June 27, 2025. This milestone follows the company's IPO in March 2025 and is part of Russell's annual reconstitution process that captures the 4,000 largest U.S. stocks by market capitalization. The inclusion signifies Kestra's growing market presence, with approximately $10.6 trillion in assets benchmarked against Russell U.S. indexes. CEO Brian Webster emphasized the company's commitment to protecting patients at risk of sudden cardiac arrest while creating long-term shareholder value.

Positive

• Inclusion in widely followed Russell 2000 and Russell 3000 indexes increases visibility to institutional investors
• Automatic inclusion provides exposure to index funds and institutional investment strategies
• Recognition of company growth since March 2025 IPO

Negative

• None.

KIRKLAND, Wash., June 23, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that the company will be added to the Russell 3000^® Index, with automatic inclusion in the Russell 2000^® Index, effective after the U.S. market close on June 27.

The annual reconstitution of the Russell indexes captures the 4,000 largest U.S. stocks as of April 30, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000^® Index results in automatic inclusion in the large-cap Russell 1000 Index or small-cap Russell 2000 Index and the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $10.6 trillion in assets are benchmarked against the Russell U.S. indexes.

“We are honored to be included in the Russell indexes,” said Brian Webster, President and CEO of Kestra Medical Technologies. “The inclusion of Kestra in the Russell indexes following our March 2025 initial public offering is a significant milestone in our public company journey. As we continue to expand our presence across markets, we remain focused on protecting more patients at risk of sudden cardiac arrest and creating long-term value for our shareholders.”

About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.

Investor contact
Neil Bhalodkar
neil.bhalodkar@kestramedical.com

Media contact
Rhiannon Pickus
rhiannon.pickus@kestramedical.com

FAQ

What does Kestra Medical Technologies' (KMTS) inclusion in Russell indexes mean for investors?

The inclusion increases KMTS's visibility to institutional investors and index funds, as approximately $10.6 trillion in assets are benchmarked against Russell U.S. indexes, potentially increasing trading volume and institutional ownership.

When will KMTS be added to the Russell 2000 and Russell 3000 indexes?

Kestra Medical Technologies will be added to both indexes effective after the U.S. market close on June 27, 2025.

What are the requirements for inclusion in the Russell indexes?

Companies are selected based on their market capitalization ranking among the 4,000 largest U.S. stocks as of April 30 during the annual reconstitution process.

When did Kestra Medical Technologies (KMTS) go public?

Kestra Medical Technologies completed its initial public offering (IPO) in March 2025.

What is Kestra Medical Technologies' (KMTS) main business focus?

Kestra Medical Technologies is a wearable medical device and digital healthcare company focused on protecting patients at risk of sudden cardiac arrest.